Ranking Profile - Fulcrum Therapeutics Inc

Introduction

Fulcrum Therapeutics Inc (Fulcrum Therapeutics) is a drug development company. The company is involved in the discovery and development of small molecule therapies to unlock gene regulation in diseases. Its pipeline products include losmapimod for treating facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058 for treating sickle cell disease and β Thalassemia. The company also owns a proprietary product engine FulcrumSeek, which detects drug targets that can control gene expression and treat the root cause of gene misexpression. The company’s key therapeutic areas include neuromuscular, muscular, hematologic, muscle, blood and central nervous system disorders. Fulcrum Therapeutics is headquartered in Cambridge, Massachusetts, the US.